首页> Cancer discovery> Targeting the p300/CBP Axis in Lethal Prostate Cancer.

Targeting the p300/CBP Axis in Lethal Prostate Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Jonathan,Welti

第一单位： The Institute of Cancer Research, London, United Kingdom.

作者： Jonathan,Welti ^[1] ; Adam,Sharp ^[2] ; Nigel,Brooks ^[3] ; Wei,Yuan ^[1] ; Christopher,McNair ^[4] ; Saswati N,Chand ^[4] ; Abhijit,Pal ^[5] ; Ines,Figueiredo ^[1] ; Ruth,Riisnaes ^[1] ; Bora,Gurel ^[1] ; Jan,Rekowski ^[1] ; Denisa,Bogdan ^[1] ; William,West ^[3] ; Barbara,Young ^[6] ; Meera,Raja ^[6] ; Amy,Prosser ^[6] ; Jordan,Lane ^[6] ; Stuart,Thomson ^[6] ; Jenny,Worthington ^[7] ; Stuart,Onions ^[6] ; Jonathan,Shannon ^[6] ; Silvia,Paoletta ^[6] ; Richard,Brown ^[6] ; Don,Smyth ^[6] ; Gareth W,Harbottle ^[6] ; Veronica S,Gil ^[1] ; Susana,Miranda ^[1] ; Mateus,Crespo ^[1] ; Ana,Ferreira ^[1] ; Rita,Pereira ^[1] ; Nina,Tunariu ^[5] ; Suzanne,Carreira ^[1] ; Antje J,Neeb ^[1] ; Jian,Ning ^[1] ; Amanda,Swain ^[1] ; David,Taddei ^[6] ; SU2C/PCF International Prostate Cancer Dream Team ^[4] ; Matthew J,Schiewer ^[4] ; Karen E,Knudsen ^[3] ; Neil,Pegg ^[8] ; Johann S,de Bono

作者单位： The Institute of Cancer Research, London, United Kingdom. ^[1] The Institute of Cancer Research, London, United Kingdom.;The Royal Marsden Hospital, London, United Kingdom. ^[2] CellCentric Ltd., Cambridge, United Kingdom. ^[3] Thomas Jefferson University, Philadelphia, Pennsylvania. ^[4] The Royal Marsden Hospital, London, United Kingdom. ^[5] Sygnature Discovery Services, Nottingham, United Kingdom. ^[6] Axis Bioservices, Coleraine, Northern Ireland. ^[7] The Institute of Cancer Research, London, United Kingdom. johann.de-bono@icr.ac.uk.;The Royal Marsden Hospital, London, United Kingdom. ^[8]